Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
Cipla Ltd, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, is announced the appointment of Umang Vohra as Global Chief Financial and Strategy Officer and Prabir Jha as Global Chief People Officer effective 1st October 2015.
Drugs Technical Advisory Board (DTAB) recommended that only Registered Pharmacist may eligible for getting approval of wholesale license of medicines in 70th meeting of DTAB held on 18th August, 2015 at central drugs standard control organization (CDSCO).
~ Through the acquisition of InvaGen, Cipla gains scale in the US generics market with a strong manufacturing and R&D base, access to broad product portfolio and a strong customer base consisting of top wholesalers/retailers
~ Through the acquisition of Exelan, Cipla gains access to the government and institutional market in the US
Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The transaction being subject to certain closing conditions, is valued at $550 million and will be an all cash transaction. The combined revenue from these transactions is over $200 million for the year ended Dec 2014 and over $225 million in LTM June 2015.
Voluntary recall of a number of drugs have been initiated by Sun Pharma and Wockhardt from the US market due to different reasons.
Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-release Tablets USP (SR), 200 mg, 60-count bottle for "failed dissolution specification", while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg for "CGMP violations".
One-year-old infant's ability to group objects according to the names associated with them - as opposed to their appearance alone - offers a glimpse into how their vocabulary will develop by the time they are 18 months, shows a new study. The findings will appear in an upcoming issue of the open access journal Frontiers in Psychology.
Growing in severe poverty can adversely affect children's brain development, new research has found. The study was published in the journal JAMA Pediatrics.
Ezetimibe can reduce the cardiovascular problems in diabetes patients, says a new study. The drug achieved greater reductions in LDL cholesterol than statins alone, resulting in lower risks of cardiovascular events in patients with diabetes and the benefits observed in diabetics were greater than in those without diabetes.
A large clinical trial in the US has found that omega-3 supplements will not slow cognitive decline in older people, debunking earlier research that a diet high in omega-3 fatty acids can protect brain health. The paper was published in the Journal of the American Medical Association.
[adsense:336x280:8701650588]
Looking at bright screens before going to bed can affect the sleep patterns of young teenagers, reveals a new study. The study is published in the Journal of Clinical Endocrinology and Metabolism.
The Mankind Pharma has taken an initiative to spread awareness about the importance of having strong bones, among the masses. The company has been championing this cause with their specialized ‘D3 Must Campaign’ across the country by reaching out to various schools, institutes and corporates.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
